Linaclotide: a guanylate cyclase agonist for treatment of irritable bowel syndrome with constipation and chronic constipation in adults
Journal: International Journal of Basic & Clinical Pharmacology (Vol.2, No. 2)Publication Date: 2013-04-01
Authors : Deepika Tikoo Meenakshi Gupta;
Page : 224-226
Keywords : Linaclotide; Irritable bowel syndrome; Chronic constipation; Guanylate cyclase;
Abstract
Linaclotide, a 14 aminoacid peptide is an intestinal secretagogues and works by stimulating guanylate cyclase (GC-C) present in the intestinal epithelium, which leads to improvement in symptoms of irritable bowel syndrome with constipation and chronic constipation in adults. Treatments available currently for these gastrointestinal problems have not been very satisfactory and many new options are therefore being explored to provide relief to these patients. Linaclotide has shown promising results in various clinical trials and hence was approved by US Food and Drug Administration (FDA) in 2012. [Int J Basic Clin Pharmacol 2013; 2(2.000): 224-226]
Other Latest Articles
- Long term carbamazepine therapy induced acute lymphoblastic leukemia
- Aspirin induced fixed drug eruptions: a case report
- Immunomodulatory effects of fruits of Barringtonia racemosa Linn.
- Assessment of ART adverse reactions and determinants at primary hospital in Ethiopia
- Identifying learning techniques among high achievers
Last modified: 2013-04-14 20:41:21